期刊文献+

体外树突状细胞诱导细胞毒T淋巴细胞杀伤肺癌细胞A549的研究 被引量:1

Study on the lethal effect of cytotoxic lymphocyte against A549 cells induced by dendritic cells in vitro
原文传递
导出
摘要 目的 研究负载有肺癌细胞株A549可溶性抗原并携带外源粒细胞巨噬细胞集落刺激囚子(GM—CSF)基因的树突状细胞(DC)在体外激活自身T淋巴细胞形成的细胞毒T淋巴细胞(CTI.)对A549细胞的杀伤作用:方法用肺癌细胞株A549可溶性抗原致敏DC,再用含有GM—CSF外源基凶的腺病毒感染DC,将所得的DC与T细胞混合培养以形成对A549细胞有特异杀伤作用的CTL。细胞分为未处理(N—DC)组、加抗原未感染病毒(A—DC)组和加抗原感染病毒(G—A—DC)组。通过测定乳酸脱氢酶(LDH)计算CTL对A549细胞的杀伤率。结果当CTL与A549细胞,即效应细胞与靶细胞比值(E/T)为5:1时,N—DC组的杀伤率为(1.9±0.7)%,A—DC组为(21.3±2.6)%,G—A—DC组为(34.5±4.9)%;当E/T为10:l时,N—DC组的杀伤率为(4.8±0.8)%,u—DC组为(35.4±3.6)%,G—A—DC组为(51.3±2.9)%;E/T为20:1时,N,DC组的杀伤率为(5.3--.t-O.2)%,A—DC组为(40.5±7.7)%,C—A—DC组为(72.5±4.7)%。3组之间的杀伤率差异有统计学意义(n=2,F:356,P〈0.05),通过两两比较,得出(j—A—DC组的杀伤率高于其他两组(P〈0.001),且A—DC组高于对照组(P〈0.001)。结论以帅癌细胞株A549可溶性抗原致敏的DC可诱导卅对A549具有特异杀伤作用的CTL,当所致敏的DC通过腺病毒感染而带有外源基因GM—CSF时,所诱导的细胞毒杀伤反应进一步增强。 Objective The goal of the study was to assess the lethal effect of cytotoxic lymphocyte against A549 cells induced by dendritic cells (DC) pulsed with A549 lysate and transfected with GM-CSF recombinant adenovirus. Methods The cytotoxic lymphocyte against A549 cells were induced by culturing with DCs, which pulsed with A549 antigens and transfected with GM-CSF recombinant adenovirus. The cytotoxic lymphocyte against A549 cells responses were measured by LDH release detection. Results At 5:1 of effector/target ratio, the killing rates of N-DC group, A-DC group and G-A-DC group were (1.9±0.7) %, (21.3±2.6) % and (34.5±4.9) %, respectively. At 10:1 of effector/target ratio, the killing rates of N-DC group, a-DC group and G-A-DC group were (4.8±0.8) %, (35.4±3.6) % and (51.3±2.9) %, respectively. At 20:1 of effector/target ratio, the killing rates of N-DC group, A-DC group and G-A-DC group were (5.3±0.2) %, (40.5±7.7) % and (72.5±4.7) %, respectively'. We found that the killing rate of G-A-DC group was the highest by statistics. Conclusion The cytotoxic lymphocyte against A549 cells can be induced by DCs pulsed with A549 lysate ,and the lethal effect of CTLs can be enhanced when DCs were infected with GM-CSF recombingnant adenovirus.
出处 《肿瘤研究与临床》 CAS 2011年第3期201-203,共3页 Cancer Research and Clinic
关键词 肺肿瘤 树突细胞 T淋巴细胞 细胞毒性 粒细胞巨噬细胞集落刺激因子 Lung neoplasms Dendritic cells T-lymphoeytes, eytotoxie Granuloeyte-maerophage colony-stimulating factor
  • 相关文献

参考文献9

  • 1朱雄鹏,陈志哲,林旭,胡建达,李纯团,许贞书,杨婷.GM-CSF基因腺病毒表达载体的构建及其在树突状细胞的表达[J].福建医科大学学报,2006,40(5):431-435. 被引量:3
  • 2Bepler G.Lung cancer:provoking new conceps,generating novelideas,and rekindlingenthusiasm.Cancer Control,2003,10:275-276.
  • 3Carbone DP.Thebiology of lung cancer.Semin Oncol,1997,24:388-401.
  • 4Parker SL,Tong T,Bolden S,et al.Cancer statistics,1997.CA Gancer J Clin,1997,47:5-27.
  • 5Giaccone G.Clinical impact of novel treatment strategies.Oncogene,2002,21:6970-6981.
  • 6吴一龙,王思愚,黄植蕃.过继性免疫治疗对肺癌围术期细胞免疫功能的影响[J].肿瘤研究与临床,1998,10(2):79-81. 被引量:1
  • 7Chapuis F,Rosenzwajg M,Yagello M,et al.Differentiation of human dendritic cells from monocytes in vitro.Eur J Immunol,1997,27:431-441.
  • 8Nakazaki Y,Tani K,Lin ZT,et al.Vaccine effect of granulocytemacrophage colony-stimulating factor or CD80 gene-transduced murine hematopoietic tumor cells and their cooperative enhancement of antitumor immunity.Gene Ther,1998,5:1355-1362.
  • 9Zibert A,Balzer S,Souquet M,et al.CCL3/MIP-lalpha is a potent immunostimulator when coexpressed with interleukin-2 or granulocyte-macrophage colony-stimulating factor in a leukemia/lymphoma vaccine.Hum Gene Ther,2004,15:21-34.

二级参考文献11

  • 1郑秋红,龚福生,陈蓉明,谢云青,汪相如,郑天荣.GM-CSF基因重组腺病毒载体的构建及鉴定[J].肿瘤防治杂志,2005,12(4):257-260. 被引量:6
  • 2Banchereau J,Steinman RM.Dendritic cells and the control of immunity[J].Nature,1998,392(6673):245-252.
  • 3Sallusto F,Lanzavecchia A.Efficient presentation soluble antigen by cultured dendritic cells is maintained by granulocyte/macrophage colony stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor[J].J Erp Med,1994,179(4):1109-1118.
  • 4Zhang Y,Mukaida N,Wang J,et al.Induction of dendritic-cell differentiation by granulocyte macrophage colony-stimulating factor,stem cell factor and tumor necrosis factor a in vitro from lineage-phenotypes-negative c-kit+ murine hematopoietic progenitor cels[J].Blood,1997,90:4842-4853.
  • 5Zhong L,Granelli Pipemo A,Choi Y,et al.Recombinant adenovirus is an efficient and non-perturbing genetic vector for human dendritic cells[J].Eur J Immunol,1999,29 (3):964-972.
  • 6Arthur JF,Butterfield LH,Roth MD,et al.A comparison of gene transfer methods in human dendritic cells[J].Cancer Gene Ther,1997,4(1):17-25.
  • 7Yinbin W,Shuang H.Adenovirus technology for gene manipulation and function studies[J].Drug Discovery Today,2000,5:10-16.
  • 8Nasz I,Adam E.Recombinant adenovirus vectors for gene therapy and clinical trials (a review)[J].Acta Microbiol Immunol Hung,2001,48:323-348.
  • 9Mizuguchi H,Kay MA,Hayakawa T.Approaches for generating recombinant adenovirus vectors[J].Adv Drug Deliv Rev,2001,52:165-176.
  • 10Danthinne X,Imperiale MJ.Production of first generation adenovirus vectors:a review[J].Gene Ther,2000,7:1707-1714.

共引文献2

同被引文献6

  • 1Albert ML,Sauter B,Bhardwaj N.1998.Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs.Nature,5392(6671):86-89.
  • 2Bykovskaia SN,Shurin GV,Graner S,et al.2002.Differentiation of immunostimulatory stem-cell-and monocyte-derived dendritic cells involves maturation of intracellular compartments responsible for antigen presentation and secretion.Stem Cells,20(5):380-393.
  • 3Colino J,Snapper CM.2003.Dendritic cells,new tools for vaccination.Microbes Infection,5(4):311-319.
  • 4Arce F,Kochan G,Breckpot K,et al.2011.Selective activation of intracellular signalling pathways in dendritic cells for cancer immunotherapy.Anti-cancer Agents in Medicinal Chemistry,11(7):455-463.
  • 5寇乐乐,王禾,于磊,武国军,刘飞,张更,武斌,麦海星.耐受性树突状细胞过继转移诱导大鼠移植肾耐受的研究[J].医学研究杂志,2008,37(10):42-44. 被引量:2
  • 6刘庆阳,姚咏明.树突状细胞体内回输对烫伤小鼠过度炎症反应的调控作用[J].感染.炎症.修复,2011,12(1):11-15. 被引量:2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部